Your browser doesn't support javascript.
loading
Cytomorphologic features of SMARCA4-deficient non-small cell lung carcinoma and correlation with immunohistochemical and molecular features.
Sun, Tong; Gilani, Syed M; Podany, Peter; Harigopal, Malini; Zhong, Minghao; Wang, He.
Afiliação
  • Sun T; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Gilani SM; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Podany P; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Harigopal M; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Zhong M; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Wang H; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
Cancer Cytopathol ; 130(8): 620-629, 2022 08.
Article em En | MEDLINE | ID: mdl-35468657
ABSTRACT

BACKGROUND:

SMARCA4/BRG1-deficient tumors and those that have loss of SMARCA/BRG1 have been described as various aggressive carcinomas and sarcomas, including a subset of non-small cell lung carcinoma (NSCLC). Cytomorphologic features of NSCLCs are yet to be described. The objective of this study was to evaluate the cytomorphologic features, immunohistochemical profile, and molecular profile of SMARCA4/BRG1-deficient NSCLC (SMARCA4-dNSCLC).

METHODS:

The authors retrospectively searched for cases with SMARCA4/BRG1 functional loss alterations, which were identified in molecular studies and further confirmed by immunocytochemistry, and they reviewed the cytomorphologic features. Tumors with BRG1 loss were also stained with an extensive antibody panel. Molecular profiling and clinical information of the identified cases were scrutinized.

RESULTS:

In total, 12 cytopathology cases from different anatomic sites were included. All cases showed variable expression of cytokeratin irrespective of type. One-half of cases had glandular features, followed by squamoid features, and poorly differentiated features. The most common cytologic features included sheets or papillary architecture, round or oval cell shapes, nuclear enlargement, moderate-to-marked pleomorphism, and coarse chromatin. Two cases with poorly differentiated cytomorphology had a predominance of single cells, scant cytoplasm, and macronucleoli. Variable expression of epithelial markers was noted in all cases. TP53 was the most frequently co-mutated gene in SMARCA4-dNSLCs.

CONCLUSIONS:

This study demonstrates that SMARCA4-dNSCLCs can have a wide spectrum of cytomorphologic features, ranging from a relatively well differentiated adenocarcinoma to a poorly differentiated/undifferentiated carcinoma, with the majority of cases exhibiting some high-grade features, such as mitosis, apoptosis, necrosis, and marked pleomorphism.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Proteínas Nucleares / Carcinoma Pulmonar de Células não Pequenas / DNA Helicases / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Cytopathol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Proteínas Nucleares / Carcinoma Pulmonar de Células não Pequenas / DNA Helicases / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Cytopathol Ano de publicação: 2022 Tipo de documento: Article